{
 "source": "Assay Systems register, https://assay-systems.com/register/",
 "key_tier": "none",
 "data": {
  "url": "https://assay-systems.com/register/ca/grants/r/oncovir-canada-inc/",
  "assay_record": "ASY-CA-08U5KK51YX",
  "summary": "2 federal grant and contribution agreements worth $4.2M with ONCOVIR CANADA INC, 2021–2021.",
  "name": "ONCOVIR CANADA INC: federal grants and contributions",
  "register": "",
  "dates": [],
  "tiles": [],
  "sections": [],
  "figures": [
   {
    "value": "2",
    "label": "agreements"
   },
   {
    "value": "$4.2M",
    "label": "value"
   },
   {
    "value": "1",
    "label": "departments"
   },
   {
    "value": "2",
    "label": "programs"
   }
  ],
  "text": [
   "The overall goal of this project is to advance the clinical development of Poly-ICLC (Hiltonol®), a broad-spectrum antiviral drug candidate, as an innovative solution to strengthen medical preparedness against viral threats.",
   "Develop immunoassay kits that can measure all three classes of SARS-CoV-2 antibodies simultaneously or individually."
  ],
  "records": [
   {
    "name": "grants and contributions register",
    "url": "https://assay-systems.com/register/ca/grants/"
   },
   {
    "name": "National Defence",
    "url": "https://assay-systems.com/register/ca/grants/department/national-defence/"
   }
  ],
  "cite_as": "Assay Systems, \"ONCOVIR CANADA INC: federal grants and contributions\", https://assay-systems.com/register/ca/grants/r/oncovir-canada-inc/"
 }
}